Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Although very few moles become cancer, abnormal or atypical moles can develop into melanoma over time
Ambient: Unacceptable
MaghrabyMKLiBChiLLingCBenmoussaAProvostPet al
The candidate previously demonstrated promising weight loss outcomes in Phase 2 trials, and its progression into late-stage testing underscores the competitive momentum building in this high-growth therapeutic category In January 2024, Zealand Pharma and Boehringer Ingelheim announced positive Phase 2 results for BI 456906, a long-acting GLP-1/glucagon dual agonist, in obese individuals
Physical format Supplied as a lyophilized (freeze-dried) powder in a sealed vial
US$ 27.41
US$ 22.76
US$ 22.57
US$ 20.83
US$ 25.10
US$ 28.76
US$ 29.95
